Critical Outcome Technologies Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Critical Outcome Technologies Inc.

Critical Outcome Technologies Inc. | Key People and Executives

Alison D. Silva

President, CEO & Non-Independent Director

John Matthew Bond

Director

David Sanderson

Non-Independent Director

Bharatt M. Chowrira

Director

John C. Drake

Chairman

John Yoo

Independent Director

Bruno C. Maruzzo

Independent Director

Alison D. Silva

President, CEO & Non-Independent Director

Debi Sanderson

Director-Resourcing & Operations

Victor Hugo

Chief Financial Officer

Richard Theodore Ho

Chief Scientific Officer

Kowthar Salim

Vice President-Development

John Matthew Bond

Director

David Sanderson

Non-Independent Director

Bharatt M. Chowrira

Director

John C. Drake

Chairman

John Yoo

Independent Director

Bruno C. Maruzzo

Independent Director

View Profile

Address	Canadian Venture Building Toronto Ontario M5C 1P1 Canada
Employees	-
Website	http://cotingapharma.com
Updated	07/08/2019
Cotinga Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of cancer and other unmet medical needs. Its lead product candidate, COTI-2, treats ovarian and other gynecological cancers and restores normal cell signaling in cancer with p53 mutations. The company was founded on October 13, 2006 and is headquartered in London, Canada.